AMED logo

Amedisys (AMED) Accounts Receivable

Annual Accounts Receivable

$313.37 M
+$16.59 M+5.59%

December 31, 2023


Summary


Performance

AMED Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMEDbalance sheetmetrics:

Quarterly Accounts Receivable

$301.05 M
-$55.86 M-15.65%

September 1, 2024


Summary


Performance

AMED Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMEDbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

AMED Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.6%-3.9%
3 y3 years+22.8%+2.4%
5 y5 years+65.8%+2.4%

AMED Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+14.0%-16.2%+9.5%
5 y5-yearat high+31.9%-16.2%+26.7%
alltimeall timeat high+4628.0%-16.2%+6734.3%

Amedisys Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$301.05 M(-15.7%)
Jun 2024
-
$356.91 M(-0.7%)
Mar 2024
-
$359.36 M(+14.7%)
Dec 2023
$313.37 M(+5.6%)
$313.37 M(-1.9%)
Sep 2023
-
$319.58 M(+14.6%)
Jun 2023
-
$278.79 M(-5.2%)
Mar 2023
-
$294.12 M(-0.9%)
Dec 2022
$296.79 M(+7.9%)
$296.79 M(-1.9%)
Sep 2022
-
$302.47 M(-1.0%)
Jun 2022
-
$305.41 M(+4.0%)
Mar 2022
-
$293.58 M(+6.8%)
Dec 2021
$274.96 M(+7.8%)
$274.96 M(+0.1%)
Sep 2021
-
$274.57 M(-1.3%)
Jun 2021
-
$278.22 M(+0.9%)
Mar 2021
-
$275.63 M(+8.0%)
Dec 2020
$255.15 M(+7.4%)
$255.15 M(+1.7%)
Sep 2020
-
$250.78 M(+0.7%)
Jun 2020
-
$249.03 M(-7.3%)
Mar 2020
-
$268.55 M(+13.0%)
Dec 2019
$237.60 M(+25.7%)
$237.60 M(-6.7%)
Sep 2019
-
$254.70 M(+6.3%)
Jun 2019
-
$239.67 M(+1.4%)
Mar 2019
-
$236.44 M(+25.1%)
Dec 2018
$188.97 M(-6.1%)
$188.97 M(-3.1%)
Sep 2018
-
$195.03 M(-1.3%)
Jun 2018
-
$197.59 M(+2.4%)
Mar 2018
-
$192.94 M(-4.1%)
Dec 2017
$201.20 M(+21.2%)
$201.20 M(+13.4%)
Sep 2017
-
$177.40 M(+2.3%)
Jun 2017
-
$173.39 M(+0.4%)
Mar 2017
-
$172.71 M(+4.0%)
Dec 2016
$166.06 M(+32.8%)
$166.06 M(+2.2%)
Sep 2016
-
$162.50 M(+6.8%)
Jun 2016
-
$152.21 M(-1.1%)
Mar 2016
-
$153.86 M(+23.1%)
Dec 2015
$125.01 M(+25.9%)
$125.01 M(+2.7%)
Sep 2015
-
$121.74 M(+10.2%)
Jun 2015
-
$110.45 M(-0.2%)
Mar 2015
-
$110.65 M(+11.4%)
Dec 2014
$99.33 M(-10.6%)
$99.33 M(-3.4%)
Sep 2014
-
$102.86 M(-7.3%)
Jun 2014
-
$110.93 M(-3.8%)
Mar 2014
-
$115.35 M(+3.8%)
Dec 2013
$111.13 M(-34.3%)
$111.13 M(-0.0%)
Sep 2013
-
$111.15 M(-10.9%)
Jun 2013
-
$124.77 M(-13.8%)
Mar 2013
-
$144.66 M(-14.5%)
Dec 2012
$169.17 M(+14.3%)
$169.17 M(+3.5%)
Sep 2012
-
$163.46 M(+0.2%)
Jun 2012
-
$163.16 M(+0.8%)
Mar 2012
-
$161.83 M(+9.3%)
DateAnnualQuarterly
Dec 2011
$148.06 M(+4.6%)
$148.06 M(-2.1%)
Sep 2011
-
$151.21 M(-1.3%)
Jun 2011
-
$153.27 M(+8.0%)
Mar 2011
-
$141.92 M(+0.3%)
Dec 2010
$141.55 M(-5.8%)
$141.55 M(-6.8%)
Jun 2010
-
$151.85 M(+0.9%)
Mar 2010
-
$150.57 M(+0.2%)
Dec 2009
$150.27 M(-14.5%)
$150.27 M(+6.6%)
Sep 2009
-
$141.01 M(-8.6%)
Jun 2009
-
$154.28 M(-0.1%)
Mar 2009
-
$154.37 M(-12.1%)
Dec 2008
$175.70 M(+82.4%)
$175.70 M(-2.3%)
Sep 2008
-
$179.77 M(+11.1%)
Jun 2008
-
$161.86 M(+12.4%)
Mar 2008
-
$144.07 M(+49.6%)
Dec 2007
$96.31 M(+28.5%)
$96.31 M(+11.3%)
Sep 2007
-
$86.55 M(+15.4%)
Jun 2007
-
$75.03 M(+10.5%)
Mar 2007
-
$67.93 M(-9.3%)
Dec 2006
$74.93 M(+10.0%)
$74.93 M(-7.6%)
Sep 2006
-
$81.11 M(+27.1%)
Jun 2006
-
$63.81 M(-5.3%)
Mar 2006
-
$67.40 M(-1.1%)
Dec 2005
$68.14 M(+178.4%)
$68.14 M(+15.1%)
Sep 2005
-
$59.21 M(+60.1%)
Jun 2005
-
$36.99 M(+48.9%)
Mar 2005
-
$24.85 M(+1.5%)
Dec 2004
$24.48 M(+61.2%)
$24.48 M(+34.0%)
Sep 2004
-
$18.27 M(-7.9%)
Jun 2004
-
$19.84 M(+33.2%)
Mar 2004
-
$14.89 M(-1.9%)
Dec 2003
$15.19 M(+7.7%)
$15.19 M(+31.3%)
Sep 2003
-
$11.57 M(+22.7%)
Jun 2003
-
$9.42 M(-7.9%)
Mar 2003
-
$10.23 M(-27.5%)
Dec 2002
$14.10 M(-40.5%)
$14.10 M(-5.2%)
Sep 2002
-
$14.88 M(-1.5%)
Jun 2002
-
$15.11 M(+182.6%)
Mar 2002
-
$5.35 M(-77.4%)
Dec 2001
$23.68 M(+257.3%)
$23.68 M(+125.2%)
Sep 2001
-
$10.52 M(+138.8%)
Jun 2001
-
$4.41 M(-54.8%)
Mar 2001
-
$9.75 M(+47.2%)
Dec 2000
$6.63 M(-52.5%)
$6.63 M(-44.2%)
Sep 2000
-
$11.87 M(-2.3%)
Jun 2000
-
$12.15 M(+20.4%)
Mar 2000
-
$10.10 M(+35.4%)
Dec 1999
$13.94 M(+87.0%)
-
Dec 1998
$7.46 M(-22.6%)
$7.46 M(-22.6%)
Dec 1997
$9.63 M(+16.4%)
$9.63 M(+16.4%)
Dec 1996
$8.27 M
$8.27 M

FAQ

  • What is Amedisys annual accounts receivable?
  • What is the all time high annual accounts receivable for Amedisys?
  • What is Amedisys annual accounts receivable year-on-year change?
  • What is Amedisys quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Amedisys?
  • What is Amedisys quarterly accounts receivable year-on-year change?

What is Amedisys annual accounts receivable?

The current annual accounts receivable of AMED is $313.37 M

What is the all time high annual accounts receivable for Amedisys?

Amedisys all-time high annual accounts receivable is $313.37 M

What is Amedisys annual accounts receivable year-on-year change?

Over the past year, AMED annual accounts receivable has changed by +$16.59 M (+5.59%)

What is Amedisys quarterly accounts receivable?

The current quarterly accounts receivable of AMED is $301.05 M

What is the all time high quarterly accounts receivable for Amedisys?

Amedisys all-time high quarterly accounts receivable is $359.36 M

What is Amedisys quarterly accounts receivable year-on-year change?

Over the past year, AMED quarterly accounts receivable has changed by -$12.32 M (-3.93%)